Morgan Stanley Keeps XPeng’s Overweight Rating

1 min read Reproduced verbatim
Rating
Overweight
Unchanged
Target
$34
Unchanged
Upside
+232%
XPEV at $10.24 today
Morgan Stanley and XPeng logos

What the analyst said

Morgan Stanley analyst Tim Hsiao reiterated on December 29, 2025, a $34 price target on XPeng, while maintaining a ‘Overweight’ rating on the stock.

“XPeng Among Morgan Stanley Preferred Calls for China Auto/Mobility in 2026.

We forecast that 2026 PV wholesale volume will fall 3% YoY (or -7% YoY for domestic sales), while we estimate NEV sales will decelerate to 11% growth in 2026, implying 59% sales penetration, with PHEVs (+14%) again outgrowing BEVs (+9%) in 2026e.

Exports should remain a bright spot in 2026 with 16% YoY growth, with sales to Europe, ASEAN and LatAm each growing 20-25% YoY.

From cars to “bots”

A re-rating of multiples will likely need progressive development of non-auto initiatives (e.g., physical, embodied AI, humanoids), where the capital market proves willing to finance such development.

Stock calls

For OEMs, XPeng (XPEV.N/9868.HK), Geely (175.HK) and SAIC (600104.SS) are our preferred stocks in 1H26 for their resilient domestic and growing overseas sales as well as re-rating opportunities from a non-auto “second act”.

We would recommend investors to keep a close watch on Li Auto (LI.O/2015.HK), NIO (NIO.N/9866.HK) and BYD’s (1211.HK/002594.SZ) new launches in 2Q for potential alpha generation against meaningfully reduced expectations.

For auto parts, Hesai (HSAI.O), Minth (425.HK) and Xingyu (601799.SS) are our preferred stocks.

We prefer Zhongsheng (881.HK) among dealers in view of its profit resurgence thanks to China’s stricter scrutiny on unfair auto price competition.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

XPEV trades at $10.24. The 7 analysts who set a target in the last 3 months range from $10 to $22, with a median of $16. This $34 target is 113% above the median, the highest on the Street.

Since the note XPEV has moved −51% (from $20.78). 12-month window: day 312 of 365, closes on December 29, 2026.

Track record

This callOpen: XPEV has not reached $34 yet. This 12-month target is scored on November 11, 2026. Same target as this firm’s November 11, 2025 note, so it is scored there.

Firm track recordMorgan Stanley: 82% of its 50 targets at least a year old were reached within 12 months (#8 of 26 firms). Accuracy ranking →

Morgan Stanley on XPeng

Morgan Stanley price targets on XPeng

4 calls from September 26, 2025 to March 20, 2026. The target went from $108 to $34 (−69%). The rating stayed Buy.

Morgan Stanley targetXPEV share price
  1. March 20, 2026Kept the $34 targetBuy$34
  2. December 29, 2025 This noteKept the $34 targetBuy$34
  3. November 11, 2025Target cut from $108 (−69%)Buy$34
  4. September 26, 2025Earliest call shownBuy$108
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.